Matches in Wikidata for { <http://www.wikidata.org/entity/Q67133918> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q67133918 description "clinical trial" @default.
- Q67133918 description "ensayu clínicu" @default.
- Q67133918 description "klinisch onderzoek" @default.
- Q67133918 description "клінічне випробування" @default.
- Q67133918 name "Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma" @default.
- Q67133918 name "Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma" @default.
- Q67133918 type Item @default.
- Q67133918 label "Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma" @default.
- Q67133918 label "Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma" @default.
- Q67133918 prefLabel "Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma" @default.
- Q67133918 prefLabel "Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma" @default.
- Q67133918 P1050 Q67133918-D5F42E24-4672-4BBF-862A-AC5D60BB6D5F @default.
- Q67133918 P1132 Q67133918-A6050765-94FE-4EE0-93C1-1CF5C346A980 @default.
- Q67133918 P1476 Q67133918-00765FCF-98CE-4B53-B570-AB794B1A2522 @default.
- Q67133918 P17 Q67133918-5001060E-1B2C-47DA-B9E4-2FED0435F351 @default.
- Q67133918 P2899 Q67133918-747CDF68-E202-43A5-9FF7-44203D01EDF0 @default.
- Q67133918 P3098 Q67133918-2EF41DA8-87FD-4871-8DA6-F1CBEB922FBC @default.
- Q67133918 P31 Q67133918-53E1FE7C-1F2E-4E18-A042-C9783F30D065 @default.
- Q67133918 P580 Q67133918-E2625730-EEE6-4F92-8848-849B933880F9 @default.
- Q67133918 P582 Q67133918-13361459-2A30-41DA-91FE-5D215E25E8B8 @default.
- Q67133918 P6099 Q67133918-9A58C36C-1F0D-4380-AE9B-0305EA6188B4 @default.
- Q67133918 P767 Q67133918-ACCAC988-06FC-49DB-B005-F0E55DFB422A @default.
- Q67133918 P8363 Q67133918-2A3E38A2-462E-44DC-A209-CFDF9727B917 @default.
- Q67133918 P1050 Q609503 @default.
- Q67133918 P1132 "+32" @default.
- Q67133918 P1476 "Phase I Study of Ipilimumab, Nivolumab, and the Combination in Patients With Newly Diagnosed Glioblastoma" @default.
- Q67133918 P17 Q30 @default.
- Q67133918 P2899 "+18" @default.
- Q67133918 P3098 "NCT02311920" @default.
- Q67133918 P31 Q30612 @default.
- Q67133918 P580 "2015-04-16T00:00:00Z" @default.
- Q67133918 P582 "2017-12-31T00:00:00Z" @default.
- Q67133918 P6099 Q5452194 @default.
- Q67133918 P767 Q30270252 @default.
- Q67133918 P8363 Q78089383 @default.